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osting by EAbstract The p53 is a well-known tumor suppressor gene, the mutations of which are closely
related to the decreased differentiation of cells. Findings of studies on immunohistochemical P53
expression in odontogenic cysts are controversial. The present study was carried-out to investigate
the immunohistochemical expression of P53 protein in odontogenic cysts. Thirty parafﬁn blocks of
diagnosed odontogenic cysts were processed to determine the immunohistochemical expression of
P53 protein. Nine of the 11 odontogenic keratocysts (81.8%) expressed P53, one of three dentiger-
ous cyst cases expressed P53, while none of the 16 radicular cysts expressed P53 protein. The ﬁnd-
ings of the present work supported the reclassiﬁcation of OKC as keratocystic odontogenic tumor.
ª 2010 King Saud University. All rights reserved.1. Introduction
Odontogenic cysts constitute a group of frequent intraosseous
lesions in the jaw bones and one of the main causes of the
destruction of these bones (Ochsenius et al., 2007). The interest
in these lesions is high because of their similar radiographicathology Department, Abha
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ity. All rights reserved. Peer-
d University.
lsevierand histopathologic features but different clinical behaviors
(Ogden et al., 1992).
The p53 protein, a product of the TP53 tumor suppressor
gene, is expressed in the G1 phase of the cell cycle to allow
the repair of possible damage to DNA and to arrest cell cycle
progression to the S phase or alternatively, to induce apoptosis
of cells that cannot be repaired. A low concentration of wild
type P53 is usually found in cells because of its relatively short
half-life which is about 20 min. Its concentration increases as
its half-life is extended, which may occur due to TP53 gene
mutation, association of wild type P53 with other proteins,
or disruption of its degradation pathway (Levine, 1997 and
De Oliveira, 2008).
Under normal conditions the P53 protein is synthesized
continuously. In the nucleus, it binds to the MDM2 protein,
and the MDM2/P53 complexes exported to the cytoplasm,
where it is degraded by proteosomes. This process keeps the
cell concentration of P53 low. Thus the increase in p53 protein
Table 1 Clinical data of the studied odontogenic cysts.
Cyst type Number Mean age Gender Site
Male Female Mandible Maxilla
RC 16 (53.3%) 33 ± 15.8 11 (68.7%) 5 (31.3%) 4 (25%) 12 (75%)
OKC 11 (36.7%) 37 ± 16.1 7 (63.6%) 4 (36.4%) 11 (100%) –
DS 3 (10%) 31 ± 20.2 3 (100) – 3 (100%) –
Total 30 35.2 ± 16.5 21 (70%) 9 (30%) 18 (60%) 12 (40%)
RC: radicular cyst; OKC: odontogenic keratocyst; DC: dentigerous cyst.
Table 2 Immunohistochemical expression of P53.
Cyst type Number Positive cases (%) Negative cases (%)
RC 16 – 16 (100%)
OKC 11 9 (81.8%) 2 (18.2%)
DC 3 1 (33.3%) 2 (66.7%)
Total 30 10 (33.3%) 20 (66.7%)
RC: radicular cyst; OKC: odontogenic keratocyst; DC: dentigerous
cyst.
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tion and translation, but rather on inhibition of its degrada-
tion. Under stress, certain types of protein are released from
the nucleus to the nucleoplasm, where it binds to MDM2 or
to the MDM/P53 complex, blocking P53 export to the cyto-
plasm and later preventing its degradation, which results in
the accumulation of the P53 protein in the nucleus (Oslon
and Dundr, 2005).
Immunohistochemical studies of P53 protein expression in
odontogenic cysts yielded contradictory ﬁndings. A number
of studies showed P53 in odontogenic cysts (Piattelli et al.,
2001; Kichi et al., 2005; Suzuki et al., 2005), others reported
absence of p53 expression in odontogenic cysts (Carvalhais
et al., 1999; Piattelli et al., 2001). Therefore, the present study
was carried-out to assess the immunohistochemical expression
of P53 protein in different types of odontogenic cysts.
2. Materials and methods
The study was carried-out on 30 archival parafﬁn blocks of
odontogenic cysts, all of which were obtained from routine
surgical specimens from Mansoura Faculty of Dentistry in
Egypt. The cases comprised 16 radicular cysts (RC), 11 odon-
togenic keratocyst cases (OKC) and three dentigerous cysts
(DC). From each parafﬁn block, two 5 micron-thick parafﬁn
sections were obtained. One section was stained with hematox-
ylin and eosin for the purpose of conﬁrmatory microscopical
evaluation of the cases.
The other section was processed immunohistochemically to
assess P53 expression as follows; sections were deparaﬁnized
and then rehydrated in graded alcohols, then treated with
blocking reagent for 5 min and washed in phosphate buffer
working solution (PBS) for 5 min. One drop of monoclonal
mouse antibody to P53 (Dako, Denmark) was then placed
on the section. Negative controls were obtained by omitting
the primary antibody replacing it with two or three drops of
non speciﬁc serum.
Then slides were incubated over night in a humidity cham-
ber with two to three drops of streptavidine enzyme placed oneach slide. Then several drops of the working color reagent
(DAB) were placed on each section. Sections were counter-
stained with Myer’s hematoxylin, dehydrated and cover-
slipped and mounted using Canada balsam.
All positive epithelial nuclei from four randomly chosen
high power ﬁelds (HPFs) in each case were counted while cells
were scored as positive or negative. The proportion of immu-
nohistochemically positive cells was estimated on 0–3 scale;
with 0 meaning no reactive cells; 1 meaning that up to 25%
of cells were immunoreactive; 2 meaning that from 25% to
50% of cells were immunoreactive; and 3 meaning that more
than 50% of the examined cells were immunoreactive (Ponten
et al., 2001). Data were tabulated and statistical analysis was
done with SPSS 10 software.
3. Results
3.1. Clinical ﬁndings (Table 1)
a. Age: The mean age of all the cases was 35.2 ± 16.5.
OKC cases showed the highest mean age (37 ± 16.1)
followed by RC group (33 ± 15.8) while the DC cases
had the lowest mean age (31 ± 20.2).
b. Gender: There were 21 males (70%) and 9 females (30%)
giving a ratio of 2: 1. All the three DC cases were males,
and, 11 (68.7%) of RC cases were males and 5 cases
(31.3%) were females of the OKC cases, 7 (63.6%) were
males and 4 (36.4%) were females.
c. Site: Eighteen cases (60%) were in the mandible and the
remaining 12 cases (40%) were in the maxilla. All OKC
and DC cases were in the mandible, Four RC cases
(25%) were reported in the mandible. All the 12 (75%)
maxillary cysts were of the RC group, 12 cases (75%).3.2. Histopathologic ﬁndings
On the examination of hematoxylin and eosin stained sections
of the studied cases the presence of cholesterol clefts and irreg-
ular epithelial lining were the prominent features of the studied
RC cases. Two DC cases had a stratiﬁed squamous epithelial
lining; the third case had two to three layers epithelial lining
with few mucous secreting cells. OKC cases had thin regular
stratiﬁed squamous epithelial lining with corrugated parakera-
tinized surface.
3.3. Immunohistochemical Findings (Table 2)
P53 expression appeared as scanty faint brown nuclear stain-
ing of the basal and Para basal cells of the epithelial lining
in studied cyst cases. Out of the 30 odontogenic cyst cases of
Figure 1 P53 expression in a dentigerous cyst case (anti-P53,
original magniﬁcation ·250).
Figure 2 P53 expression in an odontogenic keratocyst case (anti-
P53, original magniﬁcation ·250).
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their cells. All the positive cases were scored as 1 (less than
25% of their cells were reactive to anti-P53).
The present study did not reveal any P53 reactive cells
among the RC cases and only a single DC case (33.3%) ex-
pressed P53 (Fig. 1). Most of the studied OKC cases (Fig. 2)
were reactive to anti-P53, 9 cases (81.8%).
4. Discussion
The p53 is one of the most common tumor suppressor genes
located on the short arm of chromosome 17 (Isobe et al.,
1986 and Ponten et al., 2001). The disturbed function of P53
results in uncontrolled proliferation of the cell. Mutations of
P53 are present in more than 50% of malignant tumors and
are commonly related to the decreased differentiation of cells
and early recurrence (Hollstein et al., 1994).
The selection of radicular cyst (RC), odontogenic kerato-
cyst (OKC) and dentigerous cyst (DC) types for the present
study was due to their variable occurrence rates among the
odontogenic cystic lesions. The percentages of different types
of cyst cases in the present study were 53.3%, 36.7% and10% for RC, OKC and DC, respectively. The distribution of
DC and OKC was similar to that reported by Daley et al.
(1994).
The predominance of males in all the odontogenic cyst
cases of the present study was also reported in other studies
(Ochsenius et al., 2007; Tortorici et al., 2008). The study of
Ochsenius et al. (2007) yielded a similar ﬁnding to those of
the present study of the predominance of OKC and DC in
the mandible and of RC cases in the maxilla.
On the contrary to the ﬁndings in the present study of P53
expression in 33.3% of cases De Oliveira and coworkers
(2008), reported expression of P53 in all odontogenic cysts
in their study. This obvious difference might be due to the
inclusion of large number of dentigerous cysts (15 cases), cal-
cifying odontogenic cysts (10 cases) and OKCs (12 cases)
among their 48 samples, the remaining 11 cases being RC
cases.
Although Ozveren and colleagues (2003) reported 67.5%
expression of P53 in odontogenic cysts (27 out of 40 cases)
which was a higher percentage than that reported in the pres-
ent study (33.3%), in their study, positive P53 staining was re-
ported in 99% of OKC cases (10 out of 11 cases), which was
nearly similar to that reported in the present work (81.8%).
On the other hand, all the studied RC cases of the present
work were P53 negative corresponding to 45% RC cases (4
out of 9 cases) with P53 expression in Ozveren’s study
(2003). Also P53 expression in DC cases in Ozveren’s study
(2003) was reported in 13 out of 20 cases (65%) which was
higher than that of the present work (33.3%). The low P53
expression among DC cases of the present study may be due
to few number of DC cases (only 3 cases).
The difference in P53 expression between the studied odon-
togenic cysts of the present study and those of others may be
explained by the opinion of Mighell (1995), who stated that
the interpretation of immunohistochemical studies of P53
should take into consideration the complex biology of P53,
the effect of histologic processing and the protocol used for
immunohistochemical labeling, because all these factors con-
tribute to the accuracy of results.
On the other hand, other investigators reported low immu-
nohistochemical P53 expression among their studied odonto-
genic cysts as in the present study, Carvalhais et al. (1999)
reported no expression of P53 among 51 formalin ﬁxed, paraf-
ﬁn embedded specimens of odontogenic cysts and tumors.
Also, Piattelli and coworkers (2001) reported P53 expression
only in 2 out of 22 DC cases (9.1%) and in 2 out of 24 RC
cases (8.3%). Meanwhile, the present study showed higher
OKC expression of P53 (81.8%) than that of Piattelli’s study
which was (45%).
The increased P53 expression in OKC cases as compared to
that of other types of odontogenic cysts in the present study
(81.8%) was similar to the ﬁndings of Piattelli et al. (2001)
and those of Ozveren and coworkers 2003). Also, Li and
colleagues (1996) reported the highest P53 expression in
OKC (25.5 ± 11 cell/mm BM) which was signiﬁcantly higher
than that of DC (9.3 ± 4.9 cell/mm BM) and that of RC group
(6.7 ± 2.6 cell/mm BM).
The high expression of P53 in the epithelial lining of OKC
cases in the present work might mean a greater proliferative
activity of OKC epithelium, which is further supported by
the study of Jahanshahi and colleagues (2006), who reported
Bcl-2 expression in the epithelial lining of 19 out of 20 OKS.
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(1998) and data from the present study are in accord.
The expression of P53 protein in the present study was re-
ported in the basal and parabasal cells in the epithelial lining
of odontogenic cysts, which was similarly reported by others
(Li et al., 1996; Baghaei et al., 2004; De Oliveira, 2008). The ab-
sence of P53 reactivity in RC cases of the present study was sim-
ilar to the ﬁndings of Carvalhais and coworkers (1999) who
reported no P53 expression in their RC cases and to those of
Piattelli and colleagues (2001), who reported only 2 P53 reac-
tive cases among 24 RC cases.
Other investigators who reported P53 expression in the epi-
thelial lining of RC and DC cases (De Paula et al., 2000; De
Oliveira et al., 2008) denied the presence of increased prolifer-
ative activity in the epithelial lining of DC and RC, and they
suggested an inductive effect of sub epithelial inﬂammatory
inﬁltrate on the cyst epithelium inducing it’s proliferation.
Therefore, the ﬁndings of the present study of absence of
P53 expression in RC cases and P53 expression in only a single
DC case suggested a low proliferative activity of the epithelial
lining of RC and DC. The absence of P53 expression in RC
and very low expression in DC cases of the present work can
be explained by very short half-life of P53 protein in normal
tissue, so cannot be detected using immunohistochemistry
(Warnakulasuriya and Johnson, 1994).
Our ﬁndings suggested a higher proliferative activity of the
OKC cases epithelial lining leading to high recurrence rate or
increased incidence of the development of neoplasms from
the OKC epithelial lining which can be further supported by
the new designation of OKC by the World Health Organiza-
tion (WHO) as a keratocystic odontogenic tumor (KCOT).
WHO deﬁned KCOT as a benign uni or multicystic intraosse-
ous tumor of odontogenic origin with a characteristic lining of
Parakeratinized stratiﬁed squamous epithelium and potential
for aggressive, inﬁltrative behavior (Madras and Lapointe,
2008). The ﬁndings of the present work support the reclassiﬁ-
cation of OKC as keratocystic odontogenic tumor.
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